Analisi dei report online relativi al potenziale uso errato della benzidamina

Translated title of the contribution: Analysis of online reports on the potential misuse of benzidamine

Fabrizio Schifano, Ornella Corazza, Alessandro Marchi, Giuditta di Melchiorre, Elias Sferrazza, Aurora Enea, Z. Davey, Ursula Blaszko, Paolo Deluca

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


Benzydamine/Tantum Rosa is a drug for external use. It is typically available in Europe, without the need of a medical prescription, for the treatment of vaginal inflammatory processes. Between December 2009 and January 2010, the Milan and Pavia (I) Poison Centres have identified some 50 cases of inappropriate benzydamine ingestion. Reasons for this misuse have been attributed to an allegedly misleading television advert. However, the recreational misuse of benzydamine is a well-known phenomenon in Brazil and in some EU countries as well, notably in Poland and Romania. It is here suggested that the recent increase in benzydamine misuse reports in Italy may well be associated with a parallel increase in level of online information regarding the molecule potential for misuse. According to the online reports, benzydamine is typically taken at a dosage of 1-4 sachets, dissolved in water and ingested orally. Its intake may be associated with hallucinations (mostly visual), sleeping disorders and euphoria. Only future, prospective, studies will confirm and better describe the benzydamine misuse potential
Translated title of the contributionAnalysis of online reports on the potential misuse of benzidamine
Original languageItalian
Pages (from-to)182-186
JournalRivista di Psichiatria
Issue number3
Publication statusPublished - 2013


Dive into the research topics of 'Analysis of online reports on the potential misuse of benzidamine'. Together they form a unique fingerprint.

Cite this